Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Apr;144(4):651–658.

Membranous nephropathy. Insights from Heymann nephritis.

T Cavallo 1
PMCID: PMC1887245  PMID: 8160766

Full text

PDF
651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrass C. K., Border W. A., Glassock R. J. Circulating immune complexes in rats with autologous immune complex nephritis. Lab Invest. 1980 Jul;43(1):18–27. [PubMed] [Google Scholar]
  2. Abrass C. K. Evaluation of sequential glomerular eluates from rats with Heymann nephritis. J Immunol. 1986 Jul 15;137(2):530–535. [PubMed] [Google Scholar]
  3. Adler S., Baker P. J., Johnson R. J., Ochi R. F., Pritzl P., Couser W. G. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest. 1986 Mar;77(3):762–767. doi: 10.1172/JCI112372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Adler S., Salant D. J., Dittmer J. E., Rennke H. G., Madaio M. P., Couser W. G. Mediation of proteinuria in membranous nephropathy due to a planted glomerular antigen. Kidney Int. 1983 Jun;23(6):807–815. doi: 10.1038/ki.1983.99. [DOI] [PubMed] [Google Scholar]
  5. Agodoa L. Y., Gauthier V. J., Mannik M. Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med. 1983 Oct 1;158(4):1259–1271. doi: 10.1084/jem.158.4.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bagchus W. M., Vos J. T., Hoedemaeker P. J., Bakker W. W. The specificity of nephritogenic antibodies. III. Binding of anti-Fx1A antibodies in glomeruli is dependent on dual specificity. Clin Exp Immunol. 1986 Mar;63(3):639–647. [PMC free article] [PubMed] [Google Scholar]
  7. Baker P. J., Ochi R. F., Schulze M., Johnson R. J., Campbell C., Couser W. G. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol. 1989 Jul;135(1):185–194. [PMC free article] [PubMed] [Google Scholar]
  8. Bhan A. K., Schneeberger E. E., Baird L. G., Collins A. B., Kamata K., Bradford D., Erikson M. E., McCluskey R. T. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis. Lab Invest. 1985 Oct;53(4):421–432. [PubMed] [Google Scholar]
  9. Biemesderfer D., Dekan G., Aronson P. S., Farquhar M. G. Biosynthesis of the gp330/44-kDa Heymann nephritis antigenic complex: assembly takes place in the ER. Am J Physiol. 1993 Jun;264(6 Pt 2):F1011–F1020. doi: 10.1152/ajprenal.1993.264.6.F1011. [DOI] [PubMed] [Google Scholar]
  10. Camussi G., Noble B., Van Liew J., Brentjens J. R., Andres G. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease. J Immunol. 1986 Mar 15;136(6):2127–2135. [PubMed] [Google Scholar]
  11. Collins A. B., Andres G. A., McCluskey R. T. Lack of evidence for a role of renal tubular antigen in human membranous glomerulonephritis. Nephron. 1981;27(6):297–301. doi: 10.1159/000182074. [DOI] [PubMed] [Google Scholar]
  12. Couser W. G., Abrass C. K. Pathogenesis of membranous nephropathy. Annu Rev Med. 1988;39:517–530. doi: 10.1146/annurev.me.39.020188.002505. [DOI] [PubMed] [Google Scholar]
  13. Couser W. G., Baker P. J., Adler S. Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int. 1985 Dec;28(6):879–890. doi: 10.1038/ki.1985.214. [DOI] [PubMed] [Google Scholar]
  14. Couser W. G., Steinmuller D. R., Stilmant M. M., Salant D. J., Lowenstein L. M. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest. 1978 Dec;62(6):1275–1287. doi: 10.1172/JCI109248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cybulsky A. V., Bonventre J. V., Quigg R. J., Lieberthal W., Salant D. J. Cytosolic calcium and protein kinase C reduce complement-mediated glomerular epithelial injury. Kidney Int. 1990 Nov;38(5):803–811. doi: 10.1038/ki.1990.274. [DOI] [PubMed] [Google Scholar]
  16. Cybulsky A. V., Lieberthal W., Quigg R. J., Rennke H. G., Salant D. J. A role for thromboxane in complement-mediated glomerular injury. Am J Pathol. 1987 Jul;128(1):45–51. [PMC free article] [PubMed] [Google Scholar]
  17. Cybulsky A. V., Quigg R. J., Salant D. J. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy. J Immunol. 1986 Sep 1;137(5):1511–1516. [PubMed] [Google Scholar]
  18. Cybulsky A. V., Rennke H. G., Feintzeig I. D., Salant D. J. Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest. 1986 Apr;77(4):1096–1107. doi: 10.1172/JCI112408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Donadio J. V., Jr, Torres V. E., Velosa J. A., Wagoner R. D., Holley K. E., Okamura M., Ilstrup D. M., Chu C. P. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int. 1988 Mar;33(3):708–715. doi: 10.1038/ki.1988.56. [DOI] [PubMed] [Google Scholar]
  21. Douglas M. F., Rabideau D. P., Schwartz M. M., Lewis E. J. Evidence of autologous immune-complex nephritis. N Engl J Med. 1981 Nov 26;305(22):1326–1329. doi: 10.1056/NEJM198111263052206. [DOI] [PubMed] [Google Scholar]
  22. Edgington T. S., Glassock R. J., Dixon F. J. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med. 1968 Mar 1;127(3):555–572. doi: 10.1084/jem.127.3.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Falk R. J., Podack E., Dalmasso A. P., Jennette J. C. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol. 1987 Apr;127(1):182–190. [PMC free article] [PubMed] [Google Scholar]
  24. Fleuren G. J., Grond J., Hoedemaeker P. J. The pathogenetic role of free-circulating antibody in autologous immune complex glomerulonephritis. Clin Exp Immunol. 1980 Aug;41(2):205–217. [PMC free article] [PubMed] [Google Scholar]
  25. GERMUTH F. G., PACE M. G., TIPPETT J. C. Comparative histologic and immunologic studies in rabbits of induced hypersensitivity of the serum sickness type. II. The effect of sensitization to homologous and cross-reactive antigens on the rate of antigen elimination and the development of allergic lesions. J Exp Med. 1955 Feb 1;101(2):135–150. doi: 10.1084/jem.101.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. HEYMANN W., HACKEL D. B., HARWOOD S., WILSON S. G., HUNTER J. L. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med. 1959 Apr;100(4):660–664. doi: 10.3181/00379727-100-24736. [DOI] [PubMed] [Google Scholar]
  27. Hogendoorn P. C., Bruijn J. A., vd Broek L. J., De Heer E., Foidart J. M., Hoedemaeker P. J., Fleuren G. J. Antibodies to purified renal tubular epithelial antigens contain activity against laminin, fibronectin, and type IV collagen. Lab Invest. 1988 Mar;58(3):278–286. [PubMed] [Google Scholar]
  28. Hori M. T., Abrass C. K. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy. J Immunol. 1990 May 15;144(10):3849–3855. [PubMed] [Google Scholar]
  29. Jeraj K., Vernier R. L., Sisson S. P., Michael A. F. A new glomerular antigen in passive Heymann's nephritis. Br J Exp Pathol. 1984 Aug;65(4):485–498. [PMC free article] [PubMed] [Google Scholar]
  30. Kamata K., Baird L. G., Erikson M. E., Collins A. B., McCluskey R. T. Characterization of antigens and antibody specificities involved in Heymann nephritis. J Immunol. 1985 Oct;135(4):2400–2408. [PubMed] [Google Scholar]
  31. Kanalas J. J., Makker S. P. A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis. J Immunol. 1988 Dec 15;141(12):4152–4157. [PubMed] [Google Scholar]
  32. Kanalas J. J., Makker S. P. Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem. 1991 Jun 15;266(17):10825–10829. [PubMed] [Google Scholar]
  33. Kerjaschki D., Farquhar M. G. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med. 1983 Feb 1;157(2):667–686. doi: 10.1084/jem.157.2.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kerjaschki D., Farquhar M. G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5557–5561. doi: 10.1073/pnas.79.18.5557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kerjaschki D., Horvat R., Binder S., Susani M., Dekan G., Ojha P. P., Hillemanns P., Ulrich W., Donini U. Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis. Am J Pathol. 1987 Oct;129(1):183–191. [PMC free article] [PubMed] [Google Scholar]
  36. Kerjaschki D., Miettinen A., Farquhar M. G. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. J Exp Med. 1987 Jul 1;166(1):109–128. doi: 10.1084/jem.166.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kerjaschki D. Molecular pathogenesis of membranous nephropathy. Kidney Int. 1992 Apr;41(4):1090–1105. doi: 10.1038/ki.1992.166. [DOI] [PubMed] [Google Scholar]
  38. Kerjaschki D., Noronha-Blob L., Sacktor B., Farquhar M. G. Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border. J Cell Biol. 1984 Apr;98(4):1505–1513. doi: 10.1083/jcb.98.4.1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kerjaschki D., Schulze M., Binder S., Kain R., Ojha P. P., Susani M., Horvat R., Baker P. J., Couser W. G. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol. 1989 Jul 15;143(2):546–552. [PubMed] [Google Scholar]
  40. Kerjaschki D., Ullrich R., Diem K., Pietromonaco S., Orlando R. A., Farquhar M. G. Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11179–11183. doi: 10.1073/pnas.89.23.11179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Koski C. L., Ramm L. E., Hammer C. H., Mayer M. M., Shin M. L. Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3816–3820. doi: 10.1073/pnas.80.12.3816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Leung C. C., Cheewatrakoolpong B., O'Mara T., Black M. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli. Am J Anat. 1987 Jun;179(2):169–174. doi: 10.1002/aja.1001790209. [DOI] [PubMed] [Google Scholar]
  43. Lewis E. J. Idiopathic membranous nephropathy--to treat or not to treat? N Engl J Med. 1993 Jul 8;329(2):127–129. doi: 10.1056/NEJM199307083290211. [DOI] [PubMed] [Google Scholar]
  44. Lianos E. A., Noble B. Glomerular leukotriene synthesis in Heymann nephritis. Kidney Int. 1989 Dec;36(6):998–1002. doi: 10.1038/ki.1989.293. [DOI] [PubMed] [Google Scholar]
  45. Lundstrom M., Orlando R. A., Saedi M. S., Woodward L., Kurihara H., Farquhar M. G. Immunocytochemical and biochemical characterization of the Heymann nephritis antigenic complex in rat L2 yolk sac cells. Am J Pathol. 1993 Nov;143(5):1423–1435. [PMC free article] [PubMed] [Google Scholar]
  46. Makker S. P., Singh A. K. Characterization of the antigen (gp600) of Heymann nephritis. Lab Invest. 1984 Mar;50(3):287–293. [PubMed] [Google Scholar]
  47. Mannik M., Agodoa L. Y., David K. A. Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med. 1983 May 1;157(5):1516–1528. doi: 10.1084/jem.157.5.1516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Miettinen A., Törnroth T., Ekblom P., Virtanen I., Linder E. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis. Lab Invest. 1984 Apr;50(4):435–446. [PubMed] [Google Scholar]
  49. Moestrup S. K., Gliemann J., Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 1992 Sep;269(3):375–382. doi: 10.1007/BF00353892. [DOI] [PubMed] [Google Scholar]
  50. Naruse T., Fukasawa T., Miyakawa Y. Laboratory model of membranous glomerulonephritis in rats induced by pronase-digested homologous renal tubular epithelial antigen. Lab Invest. 1975 Aug;33(2):141–146. [PubMed] [Google Scholar]
  51. Natori Y., Hayakawa I., Shibata S. Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities. Clin Exp Immunol. 1987 Jul;69(1):33–40. [PMC free article] [PubMed] [Google Scholar]
  52. Natorio Y., Hayakawa I., Shibata S. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats. Am J Pathol. 1989 Feb;134(2):405–410. [PMC free article] [PubMed] [Google Scholar]
  53. Neale T. J., Ullrich R., Ojha P., Poczewski H., Verhoeven A. J., Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3645–3649. doi: 10.1073/pnas.90.8.3645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Orlando R. A., Farquhar M. G. Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4082–4086. doi: 10.1073/pnas.90.9.4082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Orlando R. A., Kerjaschki D., Kurihara H., Biemesderfer D., Farquhar M. G. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6698–6702. doi: 10.1073/pnas.89.15.6698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Pietromonaco S., Kerjaschki D., Binder S., Ullrich R., Farquhar M. G. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1811–1815. doi: 10.1073/pnas.87.5.1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Quigg R. J., Cybulsky A. V., Jacobs J. B., Salant D. J. Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells. Kidney Int. 1988 Jul;34(1):43–52. doi: 10.1038/ki.1988.143. [DOI] [PubMed] [Google Scholar]
  58. Raychowdhury R., Niles J. L., McCluskey R. T., Smith J. A. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science. 1989 Jun 9;244(4909):1163–1165. doi: 10.1126/science.2786251. [DOI] [PubMed] [Google Scholar]
  59. Rodman J. S., Kerjaschki D., Merisko E., Farquhar M. G. Presence of an extensive clathrin coat on the apical plasmalemma of the rat kidney proximal tubule cell. J Cell Biol. 1984 May;98(5):1630–1636. doi: 10.1083/jcb.98.5.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Salant D. J., Belok S., Madaio M. P., Couser W. G. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest. 1980 Dec;66(6):1339–1350. doi: 10.1172/JCI109987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Schulze M., Baker P. J., Perkinson D. T., Johnson R. J., Ochi R. F., Stahl R. A., Couser W. G. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int. 1989 Jan;35(1):60–68. doi: 10.1038/ki.1989.8. [DOI] [PubMed] [Google Scholar]
  62. Schulze M., Donadio J. V., Jr, Pruchno C. J., Baker P. J., Johnson R. J., Stahl R. A., Watkins S., Martin D. C., Wurzner R., Gotze O. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int. 1991 Sep;40(3):533–538. doi: 10.1038/ki.1991.242. [DOI] [PubMed] [Google Scholar]
  63. Shah S. V. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol. 1988 Mar;254(3 Pt 2):F337–F344. doi: 10.1152/ajprenal.1988.254.3.F337. [DOI] [PubMed] [Google Scholar]
  64. Shah S. V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 1989 May;35(5):1093–1106. doi: 10.1038/ki.1989.96. [DOI] [PubMed] [Google Scholar]
  65. Shemesh O., Ross J. C., Deen W. M., Grant G. W., Myers B. D. Nature of the glomerular capillary injury in human membranous glomerulopathy. J Clin Invest. 1986 Mar;77(3):868–877. doi: 10.1172/JCI112384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Stahl R. A., Adler S., Baker P. J., Chen Y. P., Pritzl P. M., Couser W. G. Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int. 1987 May;31(5):1126–1131. doi: 10.1038/ki.1987.118. [DOI] [PubMed] [Google Scholar]
  67. Sugisaki T., Klassen J., Andres G. A., Milgrom F., McCluskey R. T. Passive transfer of Heymann nephritis with serum. Kidney Int. 1973 Feb;3(2):66–73. doi: 10.1038/ki.1973.13. [DOI] [PubMed] [Google Scholar]
  68. Thorpe L. W., Cavallo T. Renal tubule brush border antigens: failure to confirm a pathogenetic role in human membranous glomerulonephritis. J Clin Lab Immunol. 1980 Mar;3(2):125–127. [PubMed] [Google Scholar]
  69. Van Damme B. J., Fleuren G. J., Bakker W. W., Vernier R. L., Hoedemaeker P. J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest. 1978 Apr;38(4):502–510. [PubMed] [Google Scholar]
  70. Verroust P., Ronco P., Chatelet F. Antigenic targets in membranous glomerulonephritis. Springer Semin Immunopathol. 1987;9(4):341–358. doi: 10.1007/BF00197213. [DOI] [PubMed] [Google Scholar]
  71. Watanabe K., Kinoshita S., Nakagawa H. Gelatinase secretion by glomerular epithelial cells. Nephron. 1990;56(4):405–409. doi: 10.1159/000186184. [DOI] [PubMed] [Google Scholar]
  72. Whitworth J. A., Leibowitz S., Kennedy M. C., Cameron J. S., Evans D. J., Glassock R. J., Schoenfeld L. S. Absence of glomerular renal tubular epithelial antigen in membranous glomerulonephritis. Clin Nephrol. 1976 Apr;5(4):159–162. [PubMed] [Google Scholar]
  73. Willnow T. E., Goldstein J. L., Orth K., Brown M. S., Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem. 1992 Dec 25;267(36):26172–26180. [PubMed] [Google Scholar]
  74. Zager R. A., Couser W. G., Andrews B. S., Bolton W. K., Pohl M. A. Membranous nephropathy: a radioimmunologic search for anti-renal tubular epithelial antibodies and circulating immune complexes. Nephron. 1979;24(1):10–16. doi: 10.1159/000181675. [DOI] [PubMed] [Google Scholar]
  75. Zanetti M., Mandet C., Duboust A., Bedrossian J., Bariety J. Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant. Clin Nephrol. 1981 May;15(5):272–277. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES